The impact of anti-tumour necrosis factor therapy for rheumatoid arthritis on the use of other drugs and hospital resources in a pragmatic setting.
暂无分享,去创建一个
G. Treharne | A. Saratzis | C. Deighton | N. Erb | R. Sandhu | D. Jenkins | G. Kitas | K. Douglas | M. Tavakoli | H. Piper | K. Cassim